Objective: To investigate and compare the influence of two numerical detrusor contractility parameters, the bladder contractility index (BCI) and the maximum Watts factor (WFmax), on transurethral resection of the prostate (TURP) outcome. Methods: A retrospective study was conducted on 236 patients who had undergone urodynamic assessment preoperatively and TURP for benign prostatic obstruction. They were evaluated by International Prostate Symptom Score (IPSS) and uroflowmetry preoperatively and 3 months postoperatively. Related criteria were established to determine the overall efficacy of TURP. Logistic regression analysis and receiver operating characteristic curves were made to investigate the influence of the BCI and WFmax on TURP efficacy. Results: Among the 236 patients, 195 treatments were effective and 41 ineffective. Multivariate analysis showed that both the BCI (OR 1.038) and the WFmax (OR 1.291) could influence TURP efficacy. For predicting TURP efficacy, the optimal cut-off values of the BCI and WFmax were 98.7 and 10.27 W/m2, respectively. The AUC, sensitivity and specificity of the BCI were 0.722, 78.5% and 61.0%; those of the WFmax were 0.761, 73.9% and 73.2%, with no significant difference (p > 0.05). Conclusions: To some extent, the BCI and the WFmax can predict TURP efficacy equally well. A discrimination level of 10.27 W/m2 may be a threshold value for detrusor underactivity (DU); as regards the BCI, the current threshold value is appropriate to diagnose DU.

1.
Osman
NI
,
Chapple
CR
,
Abrams
P
,
Dmochowski
R
,
Haab
F
,
Nitti
V
, et al.
Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis
.
Eur Urol
.
2014
Feb
;
65
(
2
):
389
98
.
[PubMed]
0302-2838
2.
Liedl
B
,
Goeschen
K
,
Yassouridis
A
,
Inoue
H
,
Abendstein
B
,
Müller-Funogea
IA
, et al.
Cure of Underactive and Overactive Bladder Symptoms in Women by 1,671 Apical Sling Operations Gives Fresh Insights into Pathogenesis and Need for Definition Change
.
Urol Int
.
2019
;
103
(
2
):
228
34
.
[PubMed]
0042-1138
3.
Abrams
P
,
Cardozo
L
,
Fall
M
,
Griffiths
D
,
Rosier
P
,
Ulmsten
U
, et al.;
Standardisation Sub-committee of the International Continence Society
.
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society
.
Neurourol Urodyn
.
2002
;
21
(
2
):
167
78
.
[PubMed]
0733-2467
4.
van Koeveringe
GA
,
Vahabi
B
,
Andersson
KE
,
Kirschner-Herrmans
R
,
Oelke
M
.
Detrusor underactivity: a plea for new approaches to a common bladder dysfunction
.
Neurourol Urodyn
.
2011
Jun
;
30
(
5
):
723
8
.
[PubMed]
0733-2467
5.
Oelke
M
,
Rademakers
KL
,
van Koeveringe
GA
.
Detrusor contraction power parameters (BCI and W max) rise with increasing bladder outlet obstruction grade in men with lower urinary tract symptoms: results from a urodynamic database analysis
.
World J Urol
.
2014
Oct
;
32
(
5
):
1177
83
.
[PubMed]
0724-4983
6.
Javlé
P
,
Jenkins
SA
,
Machin
DG
,
Parsons
KF
.
Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy
.
J Urol
.
1998
Nov
;
160
(
5
):
1713
7
.
[PubMed]
0022-5347
7.
Thomas
AW
,
Cannon
A
,
Bartlett
E
,
Ellis-Jones
J
,
Abrams
P
.
The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up
.
BJU Int
.
2004
Apr
;
93
(
6
):
745
50
.
[PubMed]
1464-4096
8.
Tanaka
Y
,
Masumori
N
,
Itoh
N
,
Furuya
S
,
Ogura
H
,
Tsukamoto
T
.
Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
Int J Urol
.
2006
Nov
;
13
(
11
):
1398
404
.
[PubMed]
0919-8172
9.
Rademakers
KL
,
van Koeveringe
GA
,
Oelke
M
.
Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate
.
Curr Opin Urol
.
2016
Jan
;
26
(
1
):
3
10
.
[PubMed]
0963-0643
10.
Schäfer
W
,
Abrams
P
,
Liao
L
,
Mattiasson
A
,
Pesce
F
,
Spangberg
A
, et al.;
International Continence Society
.
Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies
.
Neurourol Urodyn
.
2002
;
21
(
3
):
261
74
.
[PubMed]
0733-2467
11.
Abrams
P
.
Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function
.
BJU Int
.
1999
Jul
;
84
(
1
):
14
5
.
[PubMed]
1464-4096
12.
Griffiths
D
.
Detrusor contractility—order out of chaos
.
Scand J Urol Nephrol Suppl
.
2004
;
38
(
215
):
93
100
.
[PubMed]
0300-8886
13.
Griffiths
DJ
.
Assessment of detrusor contraction strength or contractility
.
Neurourol Urodyn
.
1991
;
10
(
1
):
1
18
. 0733-2467
14.
Donkelaar S
CT
,
Rosier
P
,
de Kort
L
.
Comparison of three methods to analyze detrusor contraction during micturition in men over 50 years of age
.
Neurourol Urodyn
.
2017
Nov
;
36
(
8
):
2153
9
.
[PubMed]
0733-2467
15.
Griffiths
DJ
,
Van Mastrigt
R
.
The Routine Assessment of Detrusor Contraction Strength
.
Neurourol Urodyn
.
1985
;
4
(
2
):
77
87
. 0733-2467
16.
Griffiths
DJ
,
Constantinou
CE
,
van Mastrigt
R
.
Urinary bladder function and its control in healthy females
.
Am J Physiol
.
1986
Aug
;
251
(
2 Pt 2
):
R225
30
.
[PubMed]
0002-9513
17.
van Mastrigt
R
,
Rollema
HJ
.
Urethral resistance and urinary bladder contractility before and after transurethral resection as determined by the computer program CLIM
.
Neurourol Urodyn
.
1988
;
7
:
226
.0733-2467
18.
Gravas
S
(Chair), Bach T, Drake M, Gacci M, Gratzke C, Herrmann TRW, et al.
2017
EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms(LUTS), incl. Benign Prostatic Obstruction(BPO).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.